Overview

Clinical trials are carefully designed experiments that allow scientists to test their research questions on people. They are a logical, structured way to answer questions about how to prevent, treat and cure HIV or complications associated with HIV/AIDS. Clinical trials are the most effective way for scientists to assess whether the benefits of a particular treatment outweigh its risks, and if it will improve the lives of people living with HIV.

Importance of Clinical Trials

Findings in clinical research, including studies on treatments, are helping people with HIV live longer, with improvements in quality of life that were not possible ten, five or even two years ago. People living with HIV play a particularly key role in research. They help to ensure that researchers are aware of their needs and concerns, and as participants, they give researchers the scientific information required to develop treatments.

About Clinical Trials

Participating in a Clinical Trial

Once You’re Enrolled

Other Things to Consider

Clinical Trials Handbook

The material found on this site is also available as a booklet called Clinical Trials: What you need to know published by the CIHR Canadian HIV Trials Network in partnership with the Canadian AIDS Society.

Written in plain language for people living with HIV, and their families and friends, the popular booklet provides a wealth of basic information about clinical trials in a simple question-and-answer format. Chapters discuss the design of trials, how to decide whether to participate, stages of participation and other issues such as the responsibilities of volunteers, what happens if participants become ill, and the use of other drugs.

For free print copies call us at 1-800-661-4664 or email ctninfo@hivnet.ubc.ca.

Download

Latest News

Call for Nominations: Community Advisory Committee (CAC) 2018

| Uncategorized | No Comments

The CIHR Canadian HIV Trials Network (CTN/Network) is an innovative partnership funded by the Canadian Institutes of Health Research to…

Guest Blog: Dr. Nadine Kronfli on HCV treatment in Canadian prisons

| Uncategorized | No Comments

Persons in custody in Canadian prisons have a 25-fold higher rate of hepatitis C (HCV) infection than the general population….

Guest Blog: CTN Postdoc Dr. Malika Sharma

| Uncategorized | No Comments

CTN Postdoctoral Fellow Dr. Malika Sharma writes about the current state of PrEP in Canada and how CTN 303 looks to change the way these HIV prevention drugs are delivered.

Guest Blog: My Experience Interning at the CTN, Part 1

| Uncategorized | No Comments

Hi everyone! My name is Sonia, and I’m one of the Communications and Knowledge Translation Interns working with the CTN this summer.